<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T06:09:17Z</responseDate>
  <request identifier="oai:figshare.com:article/34047976" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34047976</identifier>
        <datestamp>2026-10-01T17:28:51Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Supplementary material 1.&lt;/p&gt;</dc:title>
          <dc:creator>Ranna Kíssia Alves das Neves (25157704)</dc:creator>
          <dc:creator>Leonardo Soares Bastos (3825649)</dc:creator>
          <dc:creator>Daniel Antunes Maciel Villela (8438013)</dc:creator>
          <dc:creator>Valeria Saraceni (375246)</dc:creator>
          <dc:creator>Débora Medeiros de Oliveira Cruz (25157707)</dc:creator>
          <dc:creator>Luiz Max Carvalho (9510575)</dc:creator>
          <dc:creator>Antonio Guilherme Pacheco (4251952)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>strengthen health education</dc:subject>
          <dc:subject>skin color emerged</dc:subject>
          <dc:subject>rio de janeiro</dc:subject>
          <dc:subject>public health policies</dc:subject>
          <dc:subject>occurring &amp;# 8805</dc:subject>
          <dc:subject>hospital discharge disposition</dc:subject>
          <dc:subject>four administrative databases</dc:subject>
          <dc:subject>brazil &amp;# 8217</dc:subject>
          <dc:subject>booster (&amp;# 8805</dc:subject>
          <dc:subject>analysis included demographics</dc:subject>
          <dc:subject>address social vulnerabilities</dc:subject>
          <dc:subject>52 &amp;# 8211</dc:subject>
          <dc:subject>2020 &amp;# 8211</dc:subject>
          <dc:subject>001 individuals included</dc:subject>
          <dc:subject>complete vaccination regimen</dc:subject>
          <dc:subject>significant risk factors</dc:subject>
          <dc:subject>identify factors associated</dc:subject>
          <dc:subject>annual rehospitalization rates</dc:subject>
          <dc:subject>individual vaccination status</dc:subject>
          <dc:subject>2022 ), assess</dc:subject>
          <dc:subject>19 vaccination campaign</dc:subject>
          <dc:subject>vaccination status</dc:subject>
          <dc:subject>73 ),</dc:subject>
          <dc:subject>full vaccination</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>urgently needed</dc:subject>
          <dc:subject>sus notifica</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>related variables</dc:subject>
          <dc:subject>related rehospitalization</dc:subject>
          <dc:subject>rehospitalizations due</dc:subject>
          <dc:subject>rehospitalization due</dc:subject>
          <dc:subject>record linkage</dc:subject>
          <dc:subject>racial inequities</dc:subject>
          <dc:subject>patients due</dc:subject>
          <dc:subject>main finding</dc:subject>
          <dc:subject>initial hospitalization</dc:subject>
          <dc:subject>including rehospitalization</dc:subject>
          <dc:subject>fundamental strategy</dc:subject>
          <dc:subject>deaths considered</dc:subject>
          <dc:subject>competing risks</dc:subject>
          <dc:subject>black race</dc:subject>
          <dc:subject>advanced age</dc:subject>
          <dc:subject>90 days</dc:subject>
          <dc:subject>2 infection</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;The COVID-19 pandemic posed significant challenges, including rehospitalization of patients due to SARS-CoV-2 reinfection, particularly in the context of variants of concern and Brazil’s COVID-19 vaccination campaign. This study aimed to estimate the rate of rehospitalizations due to reinfection in the municipality of Rio de Janeiro (2020–2022), assess the impact of individual vaccination status, and identify factors associated with this outcome. Cohort study including individuals aged 18 years or older who were hospitalized with Severe Acute Respiratory Illness (SARI) resulting from SARS-CoV-2 infection in Rio de Janeiro. Data from four administrative databases (SIPNI, e-SUS Notifica, SIVEP-Gripe, and SIM) were integrated through record linkage. Rehospitalizations due to reinfection were defined as those occurring ≥90 days after the initial hospitalization. Annual rehospitalization rates were calculated per 100 person-years. The analysis included demographics, hospital discharge disposition, and vaccination-related variables. Cox proportional hazards models with deaths considered as competing risks were used. Of the 59,001 individuals included, 1,957 (3.3%) experienced rehospitalization. The main finding was that a complete vaccination regimen with a booster (≥3 doses) was associated with a 39% reduction in the risk of rehospitalization (sHR: 0.61; 95% CI: 0.52–0.73), while older age, multimorbidity, and Black race/skin color emerged as significant risk factors. Full vaccination with booster doses offered protection against COVID-19-related rehospitalization; however, racial inequities, advanced age, and comorbidities remain important risk factors. Public health policies that expand periodic booster vaccination, strengthen health education, and address social vulnerabilities are urgently needed as a fundamental strategy for preventing future pandemics.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-10-01T17:28:49Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1371/journal.pone.0332281.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/_p_Supplementary_material_1_p_/34047976</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
